Suchergebnisse - "Kazandjian, Dickran"

PubPharm (46)

1

Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma

enthalten in: American journal of hematology | 2019

von Rustad, E. | Misund, K. | Bernard, E. | +24

2

Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide

enthalten in: Scientific reports | 2019

von Huang, P. | Beedie, S. | Chau, C. | +7

3

Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime time

enthalten in: Clinical advances in hematology & oncology : H&O | 2019

von Kazandjian, D. | Landgren, O.

4

Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer

enthalten in: JAMA oncology | 2019

von Kazandjian, D. | Gong, Y. | Keegan, P. | +2

CommentIn: JAMA Oncol. 2020 Feb 1;6(2):299-300. - PMID 31774467

5

Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

enthalten in: JAMA oncology | 2019

von Landgren, O. | Hofmann, J. | McShane, C. | +18

6

State of the science in smoldering myeloma : Should we be treating in the clinic?

enthalten in: Seminars in oncology | 2019

von Hill, E. | Dew, A. | Kazandjian, D.

7

Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients

enthalten in: Blood cancer journal | 2019

von Kazandjian, D. | Hill, E. | Hultcrantz, M. | +10

8

Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma

enthalten in: American Journal of Hematology | 2019

von Rustad, E. | Misund, K. | Bernard, E. | +24

9

Remission and Progression-Free Survival in Patients With Newly Diagnosed Multiple Myeloma Treated With Carfilzomib, Lenalidomide, and Dexamethasone : Five-Year Follow-up of a Phase 2 Clinical Trial

enthalten in: JAMA oncology | 2018

von Kazandjian, D. | Korde, N. | Mailankody, S. | +4

10

Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma

enthalten in: Bone marrow transplantation | 2018

von Tageja, N. | Korde, N. | Kazandjian, D. | +10

1
2
3
4
5
Nächster »
[5]